A month has gone by since the last earnings report for Pfizer (PFE). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
Hosted on MSN
Pfizer, Astellas report positive phase 3 trial results for PADCEV combination in bladder cancer treatment
Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, Astellas Pharma and Pfizer Inc. (NYSE:PFE) announced positive topline results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback